MARKET

TECH

TECH

Bio-Techne Corp
NASDAQ
55.54
-0.03
-0.05%
After Hours: 56.14 +0.6 +1.08% 18:54 04/10 EDT
OPEN
55.82
PREV CLOSE
55.57
HIGH
56.13
LOW
55.06
VOLUME
1.20M
TURNOVER
--
52 WEEK HIGH
72.06
52 WEEK LOW
45.74
MARKET CAP
8.69B
P/E (TTM)
109.42
1D
5D
1M
3M
1Y
5Y
1D
Nasdaq, S&P 500, Dow futures slip as hopes of U.S.-Iran resolution fade
Seeking Alpha · 2d ago
How Bio-Techne's Spatial Biology COMET Expansion (TECH) Has Changed Its Investment Story
Simply Wall St · 3d ago
Evercore ISI Group Maintains In-Line on Bio-Techne, Lowers Price Target to $54
Benzinga · 4d ago
Weekly Report: what happened at TECH last week (0330-0403)?
Weekly Report · 5d ago
Sihuan Pharma signs strategic R&D collaboration with Biocytogen on AI antibody platform
Reuters · 04/01 09:02
Bio-Techne’s New COMET Spatial Tools Might Change The Case For Investing In Bio-Techne (TECH)
Simply Wall St · 03/31 05:07
Weekly Report: what happened at TECH last week (0323-0327)?
Weekly Report · 03/30 09:42
Is It Time To Revisit Bio-Techne (TECH) After Recent Share Price Weakness?
Simply Wall St · 03/28 10:08
More
About TECH
Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of purified proteins and reagent solutions, most notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents and T-Cell activation technologies. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, blood gas and clinical chemistry controls and other reagents for OEM and clinical customers. This segment also manufactures and sells fully automated multiomic spatial biology instrumentation and advanced tissue-based in-situ hybridization assays (ISH) for research and clinical use.

Webull offers BIO-TECHNE Corp stock information, including NASDAQ: TECH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TECH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TECH stock methods without spending real money on the virtual paper trading platform.